Vinorelbine and interferon-α2c as second-line therapy in metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Vinorelbine and interferon-α2c as second-line therapy in metastatic renal cell carcinoma

Published:2000-03 Issue:3 Volume:11 Page:175-179
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Schmidinger Manuela,Steger Günther G,Budinsky Alexandra C,Wenzel Catharina,Brodowicz Thomas,Locker Gottfried J,Kramer Gero,Marberger Michael,Zielinski Christoph C

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference22 articles.

1. Medical treatment of advanced renal cell carcinoma: present options and future directions

2. Circadian Infusion of Floxuridine in Patients with Metastatic Renal Cell Carcinoma

3. Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial

4. Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, α-interferon (leucocyte) and tamoxifen

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon induction;iScience;2024-02

2. Cell cycle arrest in mitosis promotes interferon-induced necroptosis;Cell Death & Differentiation;2019-02-11

3. Vinorelbine’s anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas;Journal of Chemotherapy;2018-05-19

4. Prolonged survival after sequential multimodal treatment in metastatic renal cell carcinoma: two case reports and a review of the literature;Journal of Medical Case Reports;2012-09-14

5. Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches;Journal of Cancer Research and Clinical Oncology;2005-11-25